Therapy Near Me Mental Health Articles

Schizophrenia is a severe mental health disorder that affects a person’s ability to think clearly, manage emotions, make decisions, and relate to others. One of the most damaging and persistent myths about schizophrenia is that it invariably leads to violent behavior. However, the recent incident in Sydney, where Joel Cauchi has stabbed several victims at the Bondi Junction Westfield Shopping Centre, brings into focus the dangers of not providing proper mental healthcare to individuals suffering from schizophrenia. This article examines the relationship between schizophrenia, medication adherence, and the risk of violent behavior, referencing scientific studies to provide a balanced view.

Research indicates that while there is an increased risk of violent behavior in individuals with schizophrenia compared to the general population, this risk is significantly magnified by other factors, including substance abuse, history of violence, non-adherence to medication, and lack of access to comprehensive treatment.

• Substance Abuse: Numerous studies have shown that the concomitant use of alcohol or drugs is a strong predictor of violent behavior in individuals with schizophrenia, much like it is in the general population.
• Non-adherence to Medication: Medication non-adherence can exacerbate the symptoms of schizophrenia, which may increase the likelihood of aggressive behavior if psychotic symptoms become uncontrolled.

Inadequate Treatment: Many violent incidents involving individuals with schizophrenia are associated with inadequate or interrupted treatment for their condition. Lack of access to mental health services, discontinuation of medication, or inadequate treatment plans can lead to symptom exacerbation, which may increase the risk of violent behavior.

Substance Abuse: Co-occurring substance abuse, which includes drugs and alcohol, significantly increases the risk of violent behavior in individuals with schizophrenia, as well as in the general population.

Social and Economic Factors: Social exclusion, homelessness, and poverty are prominent among individuals with severe mental health issues and can contribute to incidents of violence. These factors can exacerbate feelings of isolation and desperation, which may lead to an increased risk of acting out.

1. Enhanced Access to Mental Health Services: Ensure that individuals with schizophrenia have uninterrupted access to comprehensive mental health services, including medication management, psychotherapy, and community support programs. Policies should focus on integrating mental health services with other community care facilities to provide holistic support.
2. Early Intervention Programs: Implement early intervention programs in communities and schools to identify mental health issues before they develop into more severe problems. Early intervention can significantly reduce the risk of psychiatric crises that might lead to violence.
3. Public Education Campaigns: Develop and promote public education campaigns to destigmatize mental illness, particularly schizophrenia. Education can encourage community acceptance, improve early diagnosis, and prompt treatment seeking, reducing the isolation that can contribute to severe psychological distress.
4. Substance Abuse Treatment: Integrate substance abuse treatment into mental health care programs for individuals with schizophrenia, particularly those identified with dual diagnoses. Effective management of substance abuse can significantly reduce the risk of violent behavior.
5. Legal and Supportive Housing Frameworks: Strengthen legal frameworks to support the rights of individuals with mental illness while ensuring public safety. Additionally, provide supportive housing to reduce homelessness and social instability among affected individuals..

Medication plays a critical role in managing its symptoms, including hallucinations, delusions, disorganised thinking, and social withdrawal.

Antipsychotic medications are the cornerstone of schizophrenia treatment. They are divided into two classes: typical (first-generation) and atypical (second-generation) antipsychotics.

Typical Antipsychotics

• Examples: Chlorpromazine, haloperidol, fluphenazine.
• Mechanism: These drugs primarily block dopamine D2 receptors, which is thought to mitigate the positive symptoms of schizophrenia such as hallucinations and delusions.
• Side Effects: They can cause extrapyramidal side effects (movement disorders), tardive dyskinesia (involuntary movements), and are more likely to cause neuroleptic malignant syndrome (a life-threatening neurological disorder).

Atypical Antipsychotics

• Examples: Clozapine, risperidone, olanzapine, quetiapine, aripiprazole.
• Mechanism: These medications also block dopamine receptors but have a higher affinity for serotonin receptors. This helps in managing both positive symptoms and negative symptoms of schizophrenia, such as apathy, lack of emotion, and poor social functioning.
• Side Effects: Although they have a lower risk of extrapyramidal symptoms, atypical antipsychotics can cause significant weight gain, diabetes, and increased cholesterol levels.

In addition to antipsychotics, other types of medications may be used as part of a comprehensive treatment plan for schizophrenia:

Mood Stabilizers

• Use: To control mood swings or treat co-occurring bipolar disorder symptoms.
• Examples: Lithium, valproate.

Antidepressants

• Use: To manage symptoms of depression, which are common in patients with schizophrenia.
• Examples: Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine.

Benzodiazepines

• Use: Occasionally used for short-term relief of severe anxiety or agitation.
• Examples: Lorazepam.

Cognitive Enhancers

• Use: Investigational treatments aimed at improving cognitive impairments associated with schizophrenia.
• Examples: Donepezil (typically used in Alzheimer’s disease).

The choice of medication and dosage is highly individualised based on the severity of symptoms, side effect profiles, the patient’s health history, and response to previous treatments. Regular follow-ups with healthcare providers are essential to monitor the effectiveness of the medication and make necessary adjustments.

It is critical to address the stigma surrounding schizophrenia, particularly the exaggerated fear of violence. Education plays a crucial role in changing public perceptions:

• Educational Programs: Raising awareness about schizophrenia and its management can help reduce stigma. Educational programs should focus on the realities of the condition, emphasizing that with proper treatment, individuals with schizophrenia are more likely to be victims of violence than perpetrators.
• Community Support: Integrating mental health services with community outreach can ensure better adherence to treatment and support for those with schizophrenia, reducing potential risks associated with the disorder.

While schizophrenia can be associated with an increased risk of aggressive behavior, this is typically due to a combination of factors including substance abuse and non-adherence to medication rather than the condition itself. Effective management of schizophrenia with antipsychotic medications and comprehensive support can significantly reduce this risk.

Violent incidents involving individuals with schizophrenia are complex and influenced by a multitude of factors. Effective policy making and community support structures are essential in reducing these occurrences. By addressing the root causes through comprehensive healthcare, early intervention, and societal integration, we can significantly diminish the risks associated with schizophrenia and improve the quality of life for all community members.

Medication remains a fundamental aspect of schizophrenia treatment, helping to manage its challenging symptoms and improve quality of life. As research advances, newer medications with fewer side effects and improved efficacy continue to be developed, offering hope for better management of the condition. For individuals living with schizophrenia, ongoing collaboration with healthcare professionals is key to finding the most effective medication strategy.

Take this quick self assessment

• Fazel, S., Gulati, G., Linsell, L., Geddes, J. R., & Grann, M. (2009). Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine, 6(8), e1000120.
• Swartz, M. S., Swanson, J. W., Hiday, V. A., Borum, R., Wagner, H. R., & Burns, B. J. (1998). Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. American Journal of Psychiatry, 155(2), 226-231.
• Swanson, J. W., Swartz, M. S., Van Dorn, R. A., et al. (2006). A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry, 63(5), 490-499.
• Fazel, S., Lichtenstein, P., Grann, M., Goodwin, G. M., & Långström, N. (2010). Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Archives of General Psychiatry, 67(9), 931-938.
• Silver, E. (2002). Mental disorder and violent victimization: The mediating role of involvement in conflicted social relationships. Criminology, 40(1), 191-212.
• McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996). EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22(2), 305-326.
• Muench, J., & Hamer, A. M. (2010). Adverse effects of antipsychotic medications. American Family Physician, 81(5), 617-622.
• Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., … & Davis, J. M. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet, 382(9896), 951-962.

How to get in touch

If you or your patient/NDIS clients need immediate mental healthcare assistance, feel free to get in contact with us on 1800 NEAR ME – admin@therapynearme.com.au.

If you are experiencing emotional distress, please contact Lifeline 13 11 14